National trends in the use of state-reimbursed oral lipid-lowering medications in Latvia (2012-2021)

Background and Aims: The patterns of statin use in Latvia have not been examined in any prior research. We aimed to assess trends of state-reimbursed lipid-lowering medication (LLM) use over a ten-year period in Latvia.

Source: Atherosclerosis - August 1, 2023 Category: Cardiology Authors: A. Praskilevics, I. Urtane, G. Latkovskis Source Type: research